Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

Title: Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Authors: Sonpavde, Guru P.; Sternberg, Cora N.; Loriot, Yohann; Marabelle, Aurelien; Lee, Jae Lyun; Fléchon, Aude; Roubaud, Guilhem; Pouessel, Damien; Zagonel, Vittorina; Calabro, Fabio; Banna, Giuseppe L.; Shin, Sang Joon; Vera-Badillo, Francisco E.; Powles, Thomas; Hellmis, Eva; Miranda, Paulo A.P.; Lima, Ana Rita; Emeribe, Ugochi; Oh, Sun Min; Hotte, Sebastien J.
Contributors: AstraZeneca
Source: European Journal of Cancer ; volume 163, page 55-65 ; ISSN 0959-8049
Publisher Information: Elsevier BV
Publication Year: 2022
Collection: ScienceDirect (Elsevier - Open Access Articles via Crossref)
Document Type: article in journal/newspaper
Language: English
DOI: 10.1016/j.ejca.2021.12.012
Availability: http://dx.doi.org/10.1016/j.ejca.2021.12.012; https://api.elsevier.com/content/article/PII:S0959804921012831?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0959804921012831?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.1BEBD10B
Database: BASE